Sorangicin A Is Active against <i>Chlamydia</i> in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment

Current treatment of <i>Chlamydia trachomatis</i> using doxycycline and azithromycin introduces detrimental side effects on the host’s microbiota. As a potential alternative treatment, the myxobacterial natural product sorangicin A (SorA) blocks the bacterial RNA polymerase. In this study we analyze...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Simon Graspeuntner, Katharina Koethke, Celeste Scholz, Lea Semmler, Mariia Lupatsii, Laura Kirchhoff, Jennifer Herrmann, Katharina Rox, Kathrin Wittstein, Nadja Käding, Lars C. Hanker, Marc Stadler, Mark Brönstrup, Rolf Müller, Kensuke Shima, Jan Rupp
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-04-01
coleção:	Antibiotics
Assuntos:	sorangicin A antibiotics <i>Chlamydia trachomatis</i> <i>Chlamydia muridarum</i> mouse novel therapeutics
Acesso em linha:	https://www.mdpi.com/2079-6382/12/5/795
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!